Amaero Reports 367% First-Half Revenue Growth

Why It Matters

The revenue jump highlights expanding demand for high‑performance refractory and titanium powders in defense and aerospace, while the loss reflects the capital‑intensive scaling phase. Navy validation and a multi‑year Titomic contract give Amaero a foothold in strategic U.S. supply chains.

Key Takeaways

• Revenue jumped 367% to A$7.76 million H1 2025.
• Losses widened to A$17.49 million despite sales growth.
• Argon‑recycling plant to cut costs 80%, bought 60% cheaper.
• Titomic order A$4.6 million secures five‑year powder supply.
• Navy endorses PM‑HIP as casting alternative for defense.

Pulse Analysis

The powder metallurgy market is accelerating as aerospace, defense and medical sectors seek lighter, stronger components. Amaero’s focus on refractory and titanium‑alloy spherical powders positions it at the nexus of this trend, offering near‑net‑shape parts that reduce material waste and lead times. By leveraging advanced EIGA atomisation and PM‑HIP processes, the company can meet stringent performance specifications required for mission‑critical applications, differentiating it from traditional casting suppliers.

Financially, Amaero’s 367% revenue surge is offset by a A$17.49 million loss, reflecting heavy upfront investment in production capacity and currency headwinds. The A$50 million equity raise provides runway to fund the argon‑recycling plant and a fourth atomiser, initiatives expected to slash argon consumption by roughly 80% and were secured at a 60% discount to prior estimates. These cost‑saving measures aim to improve gross margins as volume scales, while the share placement strengthens the balance sheet for further expansion.

Strategic partnerships amplify Amaero’s growth narrative. A A$4.6 million five‑year purchase agreement with Titomic secures a steady demand pipeline, and the exclusive supplier deal with Knust‑Godwin broadens market reach. Crucially, a U.S. Navy Letter of Support validates the PM‑HIP technology as a viable alternative to conventional forging, opening doors to defense contracts constrained by supply‑chain bottlenecks. Although FY2026 revenue guidance was trimmed amid U.S. funding uncertainty and a brief government shutdown, the company’s expanded manufacturing footprint and validated technology suggest a resilient path toward commercial scaling.